Can You Take a GLP-1 Medication While Breastfeeding?

Direct Answer

Current clinical guidance generally recommends waiting until after breastfeeding to start a GLP-1 medication, though the actual research so far is limited but reassuring. This is a real, evolving area, not a settled question, and it's worth a direct conversation with your provider given your specific situation.

What the Real, Current Research Shows

A 2026 study gave 11 lactating women a single 5mg dose of tirzepatide (the active ingredient in Mounjaro and Zepbound) and collected 171 milk samples: no tirzepatide was detected in 164 of them (96%), and the remaining seven contained less than 0.02% of the mother's dose. A separate, earlier 2024 study found no semaglutide in breast milk samples. Real, genuine caveats apply to both: these studied single doses, not the repeated weekly dosing real-world treatment involves, and sample sizes are small.

A Real, Important Distinction: Oral vs. Injectable

Oral semaglutide (Rybelsus, and the newer Ozempic tablet) contains an absorption enhancer called SNAC that helps the medication survive digestion, and SNAC does pass into breast milk. Because infant livers are still developing, they may not clear it as quickly as an adult would. The FDA's own labeling for these oral medications explicitly notes this concern, a real, documented distinction from the injectable forms.

Beyond Medication Transfer: The Appetite-Suppression Concern

Separate from whether the medication itself passes into breast milk, GLP-1 medications' core appetite-suppressing effect creates a real, independent concern: reduced caloric and nutrient intake can affect milk supply and nutritional adequacy for both parent and infant during a period when both genuinely depend on sufficient nutrition.

Bottom Line

The real, current evidence doesn't show documented harm to nursing infants from maternal GLP-1 use, but the data remains limited, and clinical guidelines still generally recommend waiting. This is a genuinely personal decision that depends on your specific health situation, worth discussing directly and honestly with your healthcare provider rather than deciding based on general information alone.

References

• Maven Clinic: GLP-1s and Breastfeeding, Safety Considerations to Know (2026)
• TrimRx: Breastfeeding and GLP-1, What Mothers Need to Know (March 2026)
• FDA prescribing information for oral semaglutide products

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 medication.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. This article is for general informational purposes and is not medical advice. Please consult your healthcare provider about medication use while breastfeeding.